Pretreatment EUS stage does not predict complete response (CR) to neoadjuvant chemoradiation in esophageal carcinoma

被引：0
|
作者：
Mallery, S
DeCamp, M
Bueno, R
Mentzer, S
Sugarbaker, D
Swanson, S
Van Dam, J
机构：
[1] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Div Thorac Surg, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
来源：
GASTROINTESTINAL ENDOSCOPY | 1998年 / 47卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
506
引用
收藏
页码：AB150 / AB150
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant chemoradiation therapy for the treatment of esophageal carcinoma
    Matsubara, Hisahiro
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2008, 13 (06) : 474 - 478
  • [22] Neoadjuvant chemoradiation therapy for the treatment of esophageal carcinoma
    Hisahiro Matsubara
    [J]. International Journal of Clinical Oncology, 2008, 13
  • [23] Clinical Nodal Stage and Distance of Tumor Bed to Proximal Margin Predict Recurrence in Esophageal Cancer Patients with Pathologic Complete Response After Neoadjuvant Chemoradiation and Surgery
    Alkhateeb, Khaled
    Hornick, Jason
    Cleary, James
    Wee, Jon
    Zhao, Lei
    [J]. MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 410 - 412
  • [24] Clinical Nodal Stage and Distance of Tumor Bed to Proximal Margin Predict Recurrence in Esophageal Cancer Patients with Pathologic Complete Response After Neoadjuvant Chemoradiation and Surgery
    Alkhateeb, Khaled
    Hornick, Jason
    Cleary, James
    Wee, Jon
    Zhao, Lei
    [J]. LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 410 - 412
  • [25] Clinical Nodal Stage and Distance of Tumor Bed to Proximal Margin Predict Recurrence in Esophageal Cancer Patients with Pathologic Complete Response After Neoadjuvant Chemoradiation and Surgery
    Alkhateeb, Khaled
    Hornick, Jason
    Cleary, James
    Wee, Jon
    Zhao, Lei
    [J]. MODERN PATHOLOGY, 2022, 35 : 410 - 412
  • [26] EUS assessment of response to chemoradiation in esophageal cancer patients - Response
    Agarwal, B
    Swisher, SG
    Ajani, J
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (02): : 497 - 499
  • [27] The role of comprehensive evaluation for clinical complete response in predicting pathologic complete response in patients treated with neoadjuvant chemoradiation for esophageal squamous cell carcinoma (ESCC)
    Im, H-S.
    Kang, J.
    Kim, Y-H.
    Kim, H. R.
    Kim, J. H.
    Jung, H-Y.
    Lee, G-H.
    Song, H. J.
    Kim, D. H.
    Choi, K. D.
    Lee, J. H.
    Ahn, J. Y.
    Ryu, J-S.
    Cho, K-J.
    Kim, S-B.
    Park, S. R.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 213 - 213
  • [28] Correlation of EUS measurement with pathologic assessment of neoadjuvant therapy response in esophageal carcinoma
    Willis, J
    Cooper, GS
    Isenberg, G
    Sivak, MV
    Levitan, N
    Clayman, J
    Chak, A
    [J]. GASTROINTESTINAL ENDOSCOPY, 2002, 55 (06) : 655 - 661
  • [29] Biomarkers for predicting the response of esophageal squamous cell carcinoma to neoadjuvant chemoradiation therapy
    Okumura, Hiroshi
    Uchikado, Yasuto
    Setoyama, Tetsuro
    Matsumoto, Masataka
    Owaki, Tetsuhiro
    Ishigami, Sumiya
    Natsugoe, Shoji
    [J]. SURGERY TODAY, 2014, 44 (03) : 421 - 428
  • [30] Biomarkers for predicting the response of esophageal squamous cell carcinoma to neoadjuvant chemoradiation therapy
    Hiroshi Okumura
    Yasuto Uchikado
    Tetsuro Setoyama
    Masataka Matsumoto
    Tetsuhiro Owaki
    Sumiya Ishigami
    Shoji Natsugoe
    [J]. Surgery Today, 2014, 44 : 421 - 428
12345